Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2015, Article ID 147476, 7 pages
http://dx.doi.org/10.1155/2015/147476
Research Article

Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy

1Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
2Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA
3Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA 30322, USA
4Department of Pathology, Emory University, Atlanta, GA 30322, USA
5Department of Radiation Oncology, Stanford Medical Center, Stanford, CA 94305, USA
6Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA

Received 2 April 2015; Accepted 1 July 2015

Academic Editor: Ian S. Fentiman

Copyright © 2015 Shravan Kandula et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Recht, S. B. Edge, L. J. Solin et al., “Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology,” Journal of Clinical Oncology, vol. 19, no. 5, pp. 1539–1569, 2001. View at Google Scholar · View at Scopus
  2. A. Taghian, J.-H. Jeong, E. Mamounas et al., “Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials,” Journal of Clinical Oncology, vol. 22, no. 21, pp. 4247–4254, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. E. Taylor, B. G. Haffty, R. Rabinovitch et al., “ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 4, pp. 997–1002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Rastogi, S. J. Anderson, H. D. Bear et al., “Preoperative chemotherapy: Updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27,” Journal of Clinical Oncology, vol. 26, no. 5, pp. 778–785, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. T. A. Buchholz, C. D. Lehman, J. R. Harris et al., “Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a national cancer institute conference,” Journal of Clinical Oncology, vol. 26, no. 5, pp. 791–797, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. A. Buchholz, A. Katz, E. A. Strom et al., “Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 4, pp. 880–888, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. E. H. Huang, S. L. Tucker, E. A. Strom et al., “Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy,” Journal of Clinical Oncology, vol. 22, no. 23, pp. 4639–4647, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. E. H. Huang, S. L. Tucker, E. A. Strom et al., “Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 62, no. 2, pp. 351–357, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. E. P. Mamounas, S. J. Anderson, J. J. Dignam et al., “Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of national surgical adjuvant breast and bowel project B-18 and B-27,” Journal of Clinical Oncology, vol. 30, no. 32, pp. 3960–3966, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. E. McGuire, A. M. Gonzalez-Angulo, E. H. Huang et al., “Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 4, pp. 1004–1009, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Tanioka, C. Shimizu, K. Yonemori et al., “Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy,” British Journal of Cancer, vol. 103, no. 3, pp. 297–302, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Fisher, C. Redmond, E. R. Fisher et al., “Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation,” The New England Journal of Medicine, vol. 312, no. 11, pp. 674–681, 1985. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Alvarez, E. Añorbe, P. Alcorta, F. López, I. Alonso, and J. Cortés, “Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review,” The American Journal of Roentgenology, vol. 186, no. 5, pp. 1342–1348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. Lee, J. Eatrides, A. Chau et al., “Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers,” Annals of Surgical Oncology, vol. 18, no. 1, pp. 72–77, 2011. View at Publisher · View at Google Scholar
  15. J. Nori, E. Vanzi, M. Bazzocchi et al., “Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy,” American Journal of Surgery, vol. 193, no. 1, pp. 16–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Valente, G. M. Levine, M. J. Silverstein et al., “Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging,” Annals of Surgical Oncology, vol. 19, no. 6, pp. 1825–1830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. G. Fernández, M. Fraile, N. Giménez et al., “Use of axillary ultrasound, ultrasound-fine needle aspiration biopsy and magnetic resonance imaging in the preoperative triage of breast cancer patients considered for sentinel node biopsy,” Ultrasound in Medicine and Biology, vol. 37, no. 1, pp. 16–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. K. A. Kvistad, J. Rydland, H.-B. Smethurst, S. Lundgren, H. E. Fjøsne, and O. Haraldseth, “Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI,” European Radiology, vol. 10, no. 9, pp. 1464–1471, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Yoshimura, T. Sakurai, S. Oura et al., “Evaluation of axillary lymph node status in breast cancer with MRI,” Breast Cancer, vol. 6, no. 3, pp. 249–258, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-S. An, D. H. Lee, J.-K. Yoon et al., “Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients,” Nuklearmedizin, vol. 53, no. 1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. K. L. Cooper, S. Harnan, Y. Meng et al., “Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis,” European Journal of Surgical Oncology, vol. 37, no. 3, pp. 187–198, 2011. View at Publisher · View at Google Scholar
  22. P. F. Escobar, R. J. Patrick, L. A. Rybicki, D. Hicks, D. E. Weng, and J. P. Crowe, “Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer,” Annals of Surgical Oncology, vol. 13, no. 6, pp. 783–787, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Le Scodan, J. Selz, D. Stevens et al., “Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy,” International Journal of Radiation Oncology Biology Physics, vol. 82, no. 1, pp. e1–e7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Daveau, D. Stevens, E. Brain et al., “Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?” International Journal of Radiation Oncology Biology Physics, vol. 78, no. 2, pp. 337–342, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Clarke, R. Collins, S. Darby et al., “Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials,” The Lancet, vol. 366, no. 9503, pp. 2087–2106, 2005. View at Publisher · View at Google Scholar
  26. B. L. Fowble, J. P. Einck, D. N. Kim et al., “Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer,” International Journal of Radiation Oncology Biology Physics, vol. 83, no. 2, pp. 494–503, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. I. A. Olivotto, P. T. Truong, and B. Chua, “Postmastectomy radiation therapy: who needs it?” Journal of Clinical Oncology, vol. 22, no. 21, pp. 4237–4239, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. A. K. Garg, E. A. Strom, M. D. McNeese et al., “T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 59, no. 1, pp. 138–145, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Keam, S.-A. Im, H.-J. Kim et al., “Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy,” Breast Cancer Research and Treatment, vol. 116, no. 1, pp. 153–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Nagar, E. A. Mittendorf, E. A. Strom et al., “Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 3, pp. 782–787, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Cortazar, L. Zhang, M. Untch et al., “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” The Lancet, vol. 384, no. 9938, pp. 164–172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. R. D. Tendulkar, S. Rehman, M. E. Shukla et al., “Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1–3 positive lymph nodes treated with modern systemic therapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 83, no. 5, pp. e577–e581, 2012. View at Google Scholar
  33. P. S. Yang, C. M. Chen, M. C. Liu et al., “Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status,” International Journal of Radiation Oncology Biology Physics, vol. 77, no. 2, pp. 516–522, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. L. J. Esserman, D. A. Berry, A. DeMichele et al., “Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657,” Journal of Clinical Oncology, vol. 30, no. 26, pp. 3242–3249, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. R. M. Lanning, M. Morrow, N. Riaz et al., “The effect of adjuvant trastuzumab on locoregional recurrence of human epidermal growth factor receptor 2-positive breast cancer treated with mastectomy,” Annals of Surgical Oncology, 2015. View at Publisher · View at Google Scholar · View at Scopus